… A novel coronavirus was identified from these patients, and … , the genetic information of the
novel coronavirus (nCoV) was … the coronavirus that causes COVID-19 is a beta-coronavirus in …

… lethality in COVID-19. The present perspective places a central cellular pro-inflammatory
signal pathway, NF-κB, in the context of recently published data for COVID-19 and provides a …

… This review summarizes the role of NF-κB in COVID-19 and describes its potential …
However, indisputably more studies involving patients with a severe course of COVID-19 …

… the NF-κB signalling pathway in COVID-19 are limited, the therapeutic benefits of NF-κB
inhibitors … Considering the fact, the abnormal activation of the NF-κB resulting from severe acute …

… morbidity and mortality in severe COVID-19 patients. Hence, this … NF-κB with regard to
cytokine storm in COVID-19. Moreover, the development of therapeutic strategies based on NF-κB …

… of COVID-19 and the chronic COVID-19 syndrome. NF-κB inhibition in the context of
neuro-COVID-19 … strategies for targeting the NF-κB pathway in the brain of patients with …

… So, the NF-κB pathway might help to explain why COVID-19 is … NF-κB/NFAT pathways,
hence facilitating viral replication. Finally, the NF-κB pathway in patients with COVID-19 should be …

… the risk of COVID-19 after exposure to … COVID-19 or in the risk of severe COVID-19 [1, 2].
Recently, Matsuzawa et al. suggested that RAS inhibitors do not increase the risk of COVID19. …

… COVID-19.The objective of this paper therefore is to explore the modulation NFκB pathway
as a strategy to mitigate COVID-19 … the clinical use of NFκB modulators against COVID-19. …

… of the NF-κB and JAK/STAT signaling pathways in COVID-19 patients … COVID-19 related
to the disregulation of inflammation pathways that seem to play a critical role toward COVID-19 …